Clinical trial
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small…
NCT00045162 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00045162 |
|---|---|
| Title | S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer |
| Official title | Randomized Phase III Trial of Cisplatin and Irinotecan (NSC-616348) Versus Cisplatin and Etoposide in Patients With Extensive Stage Small Cell Lung Cancer (E-SCLC) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH North Central Cancer Treatment Group Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, etoposide, irinotecan hydrochloride |
| Enrollment | 671 |
| Start date | Nov 1, 2002 |
| Primary completion | Mar 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 31, 2018 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: